# CorneaGen Inc. - Inspection Records

Source: https://www.keypedia.com/companies/corneagen-inc/63b0f20d-2789-4c29-90c7-251cd951234a

> Inspection records and compliance data for CorneaGen Inc. in Winston Salem, North Carolina. Access full analysis and detailed observations.

---

## Details

- Name: CorneaGen Inc.
- FEI Number: 3005357288
- City: Winston Salem
- State: North Carolina
- Country Name: United States
- Address Line 1: 101 N Chestnut St Ste 303
- Zip Code: 27101

## Related Documents

- [483 - CorneaGen Inc. - 2023-05-31](https://www.keypedia.com/records/483/corneagen-inc/60652608-ec6e-495e-989d-a211cd094abf) — source: FDA, date: May 31, 2023
- [FDA Inspection 1207713 - CorneaGen Inc. - 2023-05-31](https://www.keypedia.com/records/fda_inspections/corneagen-inc/9546350a-520a-418e-9e0c-472996e1ca70) — classification: No Action Indicated (NAI), source: FDA, date: May 31, 2023
- [FDA Inspection 1207713 - CorneaGen Inc. - 2023-05-31](https://www.keypedia.com/records/fda_inspections/corneagen-inc/a5146096-70a5-4e18-b1d1-ad5e2643b3e7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2023
- [FDA Inspection 1149011 - CorneaGen Inc. - 2021-07-14](https://www.keypedia.com/records/fda_inspections/corneagen-inc/29d8d155-afb4-4305-bce4-120aba4772b2) — classification: No Action Indicated (NAI), source: FDA, date: July 14, 2021
- [FDA Inspection 1061992 - CorneaGen Inc. - 2018-07-20](https://www.keypedia.com/records/fda_inspections/corneagen-inc/6319f14a-8037-434b-b4c1-17288fdbe7f9) — classification: No Action Indicated (NAI), source: FDA, date: July 20, 2018
- [FDA Inspection 946041 - CorneaGen Inc. - 2015-10-22](https://www.keypedia.com/records/fda_inspections/corneagen-inc/9b015230-b63c-4da3-a8e3-09d62c7792d7) — classification: No Action Indicated (NAI), source: FDA, date: October 22, 2015
- [FDA Inspection 870037 - CorneaGen Inc. - 2014-02-28](https://www.keypedia.com/records/fda_inspections/corneagen-inc/61c610b6-38c6-4483-8e1d-0d32b33bff12) — classification: No Action Indicated (NAI), source: FDA, date: February 28, 2014
- [FDA Inspection 773966 - CorneaGen Inc. - 2012-03-15](https://www.keypedia.com/records/fda_inspections/corneagen-inc/31198d7c-f9f2-49cb-b19c-9b4260283f50) — classification: No Action Indicated (NAI), source: FDA, date: March 15, 2012
- [FDA Inspection 639145 - CorneaGen Inc. - 2010-01-14](https://www.keypedia.com/records/fda_inspections/corneagen-inc/ebaa8683-ab89-4747-a59d-19621cef0810) — classification: No Action Indicated (NAI), source: FDA, date: January 14, 2010

## Related Companies

- [Angiodynamics, Inc.](https://www.keypedia.com/companies/angiodynamics-inc/cabf05c2-1177-4dba-93a3-ba8e56e956d6)
- [IVF Laboratory of Central Florida LLC](https://www.keypedia.com/companies/ivf-laboratory-of-central-florida-llc/a3ff8eb3-156c-47a7-9871-089f1f82f703)
- [Quest Diagnostics Nichols Institute](https://www.keypedia.com/companies/quest-diagnostics-nichols-institute/76fdabb3-2e73-453c-9461-9d20b2c531ee)
- [Wells Enterprises, Inc.](https://www.keypedia.com/companies/wells-enterprises-inc/eecae644-b8fd-4b93-a19e-cb8622c3186d)
- [ConMed Corporation](https://www.keypedia.com/companies/conmed-corporation/ab83684d-062e-47ad-9694-df520179a67e)
- [Rockwell Medical, Inc](https://www.keypedia.com/companies/rockwell-medical-inc/773d8d8c-13b2-4c27-9389-dd8993ea6d0c)
- [DePuy Orthopaedics, Inc.](https://www.keypedia.com/companies/depuy-orthopaedics-inc/19905de5-7a2b-44bb-9260-5780437c1eac)
- [Signal Medical Corporation](https://www.keypedia.com/companies/signal-medical-corporation/6995f522-0aba-4239-8317-5f6667e624c3)
- [Glanbia Nutritionals, Inc.](https://www.keypedia.com/companies/glanbia-nutritionals-inc/17591734-8491-42e8-bff1-957ee35520d9)
- [5000 Years Foods, Inc.](https://www.keypedia.com/companies/5000-years-foods-inc/cfe65e72-f5d9-4b56-acf4-87d1e94fdec7)

## Related Officers

- [investigator](https://www.keypedia.com/people/randy-l-clarida/aae3cc15-a908-4489-9299-7542370ad3cd)
- [Marla A. Cassidy](https://www.keypedia.com/people/marla-a-cassidy/d2859ca5-e77b-4385-9a96-4c785f3ac4c6)